Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
154M
-
Shares change
-
+4.46M
-
Total reported value, excl. options
-
$6.49B
-
Value change
-
+$187M
-
Put/Call ratio
-
0.74
-
Number of buys
-
116
-
Number of sells
-
-136
-
Price
-
$42.25
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q1 2020
323 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q1 2020.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 154M shares
of 170M outstanding shares and own 90.31% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (41.9M shares), FMR LLC (20.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.8M shares), VANGUARD GROUP INC (11M shares), BlackRock Inc. (10.1M shares), STATE STREET CORP (4.04M shares), CITADEL ADVISORS LLC (3.7M shares), HealthCor Management, L.P. (2.23M shares), Nuveen Asset Management, LLC (2.01M shares), and GREAT POINT PARTNERS LLC (2M shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.